Cortex of SuperAger brain deteriorated much slower than average elderly brain over time
Donald Tenbrunsel is 89 years old, but he is just as likely to talk to you about Chance the Rapper as reminisce about Frank Sinatra.
The highly engaged and delightful conversationalist, who reads, volunteers and routinely researches questions on the Internet, is part of a new path-breaking Northwestern Medicine study published in the Journal of the American Medical Association (JAMA) that shows SuperAgers’ brains shrink much slower than their age-matched peers, resulting in a greater resistance to “typical” memory loss and dementia.
Over the course of the 18-month study, normal agers lost volume in the cortex, which contains neurons, twice as fast as SuperAgers, a rare group of people aged 80 and above whose memories are as sharp as those of healthy persons decades younger.
“Increasing age is often accompanied by ‘typical’ cognitive decline or, in some cases, more severe cognitive decline called dementia,” said first author Amanda Cook, a PhD student in the Clinical Psychology Program. “SuperAgers suggest that age-related cognitive decline is not inevitable.”
Senior author Emily Rogalski, PhD, research associate professor in the Cognitive Neurology and Alzheimer’s Disease Center, will present the findings at the Cognitive Aging Summit in Washington, D.C. on April 6.
[pullquote]“SuperAgers suggest that age-related cognitive decline is not inevitable.”[/pullquote]
SuperAger Tenbrunsel, who lives with his daughter’s family, is intent on being a good conversationalist with his three grandchildren.
“I have to adapt to that kind of life,” Tenbrunsel said. “They don’t know much about Frank Sinatra or Franklin Delano Roosevelt, so I have to keep saying, ‘Is Chance the Rapper coming this week or is it Taylor Swift?’”
The scientists already knew SuperAgers’ brains were larger and typically don’t show the same wear-and-tear as normal agers.
“For this study we explored whether SuperAgers’ brains were on a different trajectory of decline,” Rogalski said. “We found that SuperAgers are resistant to the normal rate of decline that we see in average elderly, and they’re managing to strike a balance between life span and health span, really living well and enjoying their later years of life.”
Using magnetic resonance imaging (MRI), the scientists measured the thickness of the cortex in 24 SuperAgers and 12 same-age, educationally and cognitive average peers (control group) to determine the approximate health of the brain over 18 months. The annual percent decline in thickness between the first and second visit for the SuperAgers was 1.06 and 2.24 for the control group.
Previous research showed that SuperAgers have a thicker cortex than those who age normally. By studying what makes SuperAgers unique, the scientists said they hope to undercover biological factors, such as the reduced cortical brain atrophy demonstrated here, that might contribute to the maintenance of memory ability in advanced age.
SuperAger research at Northwestern is flipping the traditional approach to Alzheimer’s research of focusing on brains that are underperforming to instead focusing on outperforming brains.
“Sometimes it’s useful to turn a complex problem on its head and look from a different vantage point,” Rogalski said. “This is what the SuperAging program does. We are studying people at the opposite end of the spectrum: those with unexpectedly high memory performance for their age.”
Other Northwestern authors on the study include M. Marsel Mesulam, MD, director of the Cognitive Neurology and Alzheimer’s Disease Center and Ruth Dunbar Davee Professor of Neuroscience in the Ken and Ruth Davee Department of Neurology, Alfred Rademaker, PhD, professor of Preventive Medicine in the Division of Biostatistics, Sandra Weintraub, PhD, professor of Psychiatry and Behavioral Sciences and of Neurology, Jaiashre Sridhar and Daniel Ohm.
The research was funded by grants from the National Institutes of Health, including R01AG045571 and P30 AG13854 from the National Institute on Aging, T32 NS047987 from the National Institute of Neurological Disorders and Stroke, as well as the Davee Foundation.
